What are the barriers for diverse and inclusive clinical trial recruitment?

Immunoprevention and early detection of lung cancer in Africa: The LUNG-GUARD Platform

Accelerating access to innovative therapies in Africa

Innovation in cancer treatment and equity: ensuring emerging treatments reach all populations

Tepotinib in second line NSCLC treatment

The burden of infections in patients with cancer in Sub-Saharan Africa

Liquid biopsies as translational tools for advancing cancer immunotherapy in Africa

Integrating oncogenetics testing into African clinics and cancer control programs

Toripalimab plus chemotherapy improves 3-year survival in resectable gastric/GEJ cancer

Adjuvant pembrolizumab fails to improve recurrence-free survival after curative therapy in hepatocellular carcinoma

Physical activity reduces fatigue and improves quality of life in colorectal cancer survivors

Zanidatamab improves PFS and OS in first-line HER2-positive metastatic gastric cancer